General
Preferred name
ROSOXACIN
Synonyms
Acrosoxacin ()
Winoxacin ()
WIN-35213 ()
Eradicin ()
Eracine ()
Winuron ()
Eradacil ()
Eradacin ()
WIN 35,213 ()
NSC-146617 ()
Roxadyl ()
P&D ID
PD009704
CAS
40034-42-2
Tags
available
drug
Drug Status
investigational
approved
withdrawn
Drug indication
Bacterial infection
Antibacterial
Max Phase
Phase 4
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Rosoxacin is a quinolone antibacterial compound with activity against Gram-negative bacteria.
(GtoPdb)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
12
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Guide to Pharmacology
MedChem Express Bioactive Compound Library
ReFrame library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
26
Properties
(calculated by RDKit )
Molecular Weight
294.1
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
1
Rotatable Bonds
3
Ring Count
3
Aromatic Ring Count
3
cLogP
2.78
TPSA
72.19
Fraction CSP3
0.12
Chiral centers
0.0
Largest ring
6.0
QED
0.81
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Indication
urinary tract infections
MOA
Topoisomerase inhibitor
Therapeutic Class
Antiinfective Agents
Pathway
Anti-infection
Target
antibiotic
Bacterial
Source data